CS
STIM icon

Credit Suisse’s Neuronetics STIM Stock Holding History

Credit Suisse’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14
Closed – – 4272
2022
Q2 		$0 Buy
+14
New +$41 ﹤0.01% 4291

Other funds holding STIM

CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse's STIM Position: Q3 2022 in Review

Credit Suisse sold out of Neuronetics (STIM) in Q3 2022, closing a stake of 14 shares.

Credit Suisse first reported a position in STIM in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 76 funds tracked by Wall St. Rank hold STIM as of Q3 2022.

  • Credit Suisse reported no remaining Neuronetics position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 14 Neuronetics shares in Q3 2022.
  • Credit Suisse first reported a position in Neuronetics in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's Neuronetics position peaked at $0 in Q2 2022.
  • 76 funds tracked by Wall St. Rank held Neuronetics as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.